Drug intelligence / Profile preview

茵胆平肝胶囊

Development stage: Unknown
Lead developer: Zhangzhou Pien Tze Huang Pharmaceutical
Administration: Oral

Overview

茵胆平肝胶囊 (Yindan Pinggan Jiaonang), also known as Sanyinda, is a Traditional Chinese Medicine (TCM) formulated as capsules. It is primarily indicated for conditions associated with liver-gallbladder damp-heat syndrome, including hypochondriac pain, bitter taste in the mouth, and yellow urine. It is also used to alleviate symptoms in acute and chronic cholecystitis, gallstones, alcoholic liver disease, acute viral hepatitis, chronic hepatitis B (as an adjunct therapy), skin itching due to cholestasis, and abdominal distension. Its mechanism of action, from a TCM perspective, involves clearing heat and resolving dampness in the liver and gallbladder. The drug is manufactured by Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. and is administered orally.

Brand names: 片仔癀茵胆平肝胶囊
Other names: Sanyinda三茵胆Yindan Pinggan Jiaonang

Beyond the preview

Go deeper on 茵胆平肝胶囊.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 茵胆平肝胶囊.

Explore the full profile